S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

RAPT RAPT Therapeutics Inc

1.16

0.00 (0.00%)

Pre Market

Last Updated: 20:00:00

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

RAPT Therapeutics (NASDAQ:RAPT)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more RAPT Therapeutics Charts.

RAPT Therapeutics (NASDAQ:RAPT)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more RAPT Therapeutics Charts.

RAPT Therapeutics Inc News

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 28 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Tuesday 28 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Wednesday 22 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 14 January 2025 (1 month ago) • Edgar (US Regulatory)

RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Friday 10 January 2025 (1 month ago) • GlobeNewswire Inc.

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Tuesday 7 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 7 January 2025 (1 month ago) • Edgar (US Regulatory)

RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors
Tuesday 7 January 2025 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 24 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 23 December 2024 (2 months ago) • Edgar (US Regulatory)

RAPT Therapeutics Announces $150 Million Private Placement
Monday 23 December 2024 (2 months ago) • GlobeNewswire Inc.

RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting anti-IgE Antibody
Monday 23 December 2024 (2 months ago) • GlobeNewswire Inc.

More RAPT Therapeutics Inc News Articles

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions